Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01514396 · ClinicalTrials.gov registry record · NA
Skin Incision Adhesive in Pediatrics
A NA study, sponsored by Medline Industries.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01514396 is a NA study that has completed, run by Medline Industries. The registered enrollment target is 8 participants.
The verdict
NCT01514396, a NA study, has completed, sponsored by Medline Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of on-label use of Surgiseal™ Tissue Adhesive, a cyanoacrylate-based Surgical Topical Skin Tissue Adhesive in wound closure of the topical skin in children presenting in the Emergency Department (ED).
Interventions
- DEVICE Surgiseal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01514396
The ClinicalTrials.gov registry entry for NCT01514396 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medline Industries, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Surgiseal is the first listed.
NCT01514396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01514396 about?
NCT01514396 is a clinical study titled "Skin Incision Adhesive in Pediatrics". The purpose of this study is to evaluate the effectiveness of on-label use of Surgiseal™ Tissue Adhesive, a cyanoacrylate-based Surgical Topical Skin Tissue Adhesive in wound closure of the topical skin in children presenting in the Emergency Department (ED).
What is the current status of trial NCT01514396?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2013-02. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01514396?
The interventions under investigation include: Surgiseal (DEVICE).
Who is sponsoring clinical trial NCT01514396?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.